Fiji declared a national emergency in September 2026 as HIV infections skyrocketed, with an estimated 9,000 cases. Public health experts attribute this to a parallel epidemic of crystal meth use, particularly among young people. Two-thirds of new cases are in those aged 20-34, with injection drug use (like 'bluetoothing,' where needles are shared) being a major transmission route.
Before COVID, Fiji primarily served as a transit hub for meth destined for Australia and New Zealand. But pandemic border restrictions trapped more drugs locally, creating a new domestic market. Rising unemployment and lockdown-related despair pushed many young Fijians—some as young as 9—toward meth use, often via injection, which carries a high HIV risk.
"The majority of my friends got HIV through crystal meth," says Fijian HIV activist Mark Lal.
Why This Matters
This crisis highlights how social and economic instability can exacerbate sexual health risks. Meth use lowers inhibitions and increases unprotected sex, while shared needles directly spread HIV. Fiji’s youth—the country’s most productive demographic—are disproportionately affected, threatening long-term societal stability.
The overlap of addiction and HIV also underscores the need for harm-reduction strategies, like needle-exchange programs and PrEP (pre-exposure prophylaxis), which are currently limited in Fiji. Without intervention, experts warn the epidemic could worsen, with ripple effects across the Pacific region.
What You Can Do
Support global harm-reduction efforts: Donate to organizations providing clean needles, HIV testing, and addiction treatment in Fiji and similar regions. Advocate for policies that decriminalize drug use and expand access to PrEP and PEP (post-exposure prophylaxis), which can prevent HIV after exposure.
If you or someone you know uses injectable drugs, always use sterile needles and never share equipment. Seek local resources for addiction support and HIV testing. Education about safer drug use and sexual practices saves lives.
